Similar Articles |
|
Nursing June 2010 Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing February 2009 Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
Nursing July 2008 Daniel A. Hussar |
New Drugs08, Part 2 Here, you'll learn about eight new drugs, including doripenem, maraviroc and ixabepilone. |
Nurse Practitioner February 2012 Jennifer M. Belavic |
Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice |
Nurse Practitioner February 2011 Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
Nursing May 2012 Tim Blake |
Three Medication Pathways for Bipolar Disorder No matter where you work, you're likely to care for patients with bipolar disorder, which affects about 2.6% of people age 18 and older per year. |
American Family Physician August 15, 2005 Ward & Kugelmas |
Using Pegylated Interferon and Ribavirin to Treat Patients with Chronic Hepatitis C New treatment regimens and advances in the management of side effects and toxicities have expanded the pool of patients who can be treated with pegylated interferon and ribavirin. |
Nursing December 2008 Susan Simmons Holcomb |
Caring for a patient with chronic hepatitis C Teach your patient about improved treatments that can help him deal with this potentially deadly infection. |
American Family Physician January 15, 2003 Ables & Baughman |
Antidepressants: Update on New Agents and Indications Many antidepressants have been released in the United States over the past two decades. This article is an update of information about the newer agents for depression and new indications for older antidepressants. |
American Family Physician November 1, 2005 Steven H. Williams |
Medications for Treating Alcohol Dependence Medications for treating alcohol dependence primarily have been adjunctive interventions, and only three medications -- disulfiram, naltrexone, and acamprosate -- are approved for this indication by the U.S. Food and Drug Administration. |
American Family Physician December 1, 2000 Norman J. Montalto |
Updated Treatment for Influenza A and B The prevention of influenza is best accomplished with a broad-based immunization program... |
American Family Physician May 15, 2004 Birrer & Vemuri |
Depression in Later Life: A Diagnostic and Therapeutic Challenge Depression in elderly persons is widespread, often undiagnosed, and usually untreated. Because there is no reliable diagnostic test, a careful clinical evaluation is essential. |
American Family Physician December 1, 2002 Aukerman et al. |
Management of the Acute Migraine Headache As many as 30 million Americans have migraine headaches. The impact on patients and their families can be tremendous, and treatment of migraines can present diagnostic and therapeutic challenges for family physicians. |
Nurse Practitioner September 2010 Moloney & Cranwell-Bruce |
Pharmacological Management of Migraine Headaches Migraine is one of the top 20 causes of disability worldwide, occurring in 17.6% of women and 5.7% of men |
American Family Physician February 15, 2003 |
Antiviral Drugs in the Immunocompetent Host: Part I. Treatment of Hepatitis, Cytomegalovirus, and Herpes Infections |
American Family Physician March 15, 2004 |
Management of Hepatitis C: Evaluating Suitability for Drug Therapy Chronic hepatitis C virus infection is a common and serious disease. Although an estimated 2.7 million persons in the United States have this disease, most have not yet been diagnosed. |
American Family Physician August 15, 2003 Lesho & Gey |
Managing Issues Related to Antiretroviral Therapy HIV-related deaths and opportunistic infections have decreased dramatically since the advent of highly active antiretroviral therapy, and health care providers are focusing on management of increasingly complex drug regimens and their associated interactions and toxicities. |
Nursing February 2012 Pezzotti & Freuler |
Using anticoagulants to steer clear of clots This article will review coagulation and provide important information about several commonly used anticoagulants and their reversal agents. |
American Family Physician June 15, 2002 Jeffrey L. Cummings |
Guidelines for Managing Alzheimer's Disease: Part II. Treatment Once the clinical diagnosis of Alzheimer's disease has been made, a treatment plan must be developed. Patient symptoms and care needs change as Alzheimer's disease progresses. |
Nursing November 2011 Jeanne Held-Warmkessel |
Taming Three High-Risk Chemotherapy Complications A review of three common chemotherapy-associated complications that can be serious enough to require hospitalization: febrile neutropenia, chemotherapy-related nephrotoxicity, and chemotherapy-related enterotoxicity. |
American Family Physician February 15, 2003 |
Antiviral Drugs in the Immunocompetent Host: Part II. Treatment of Influenza and Respiratory Syncytial Virus Infections |
Nursing July 2011 Susan Simmons |
Recognizing and Managing Rheumatoid Arthritis Here's what rheumatoid arthritis is, how it's diagnosed and treated, and what you can do to help patients manage the disease. |
American Family Physician November 15, 2002 Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
Nursing January 2011 Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
American Family Physician June 1, 2003 Motsinger et al. |
Use of Atypical Antipsychotic Drugs in Patients with Dementia Increasingly, atypical antipsychotic drugs are prescribed for elderly patients with symptoms of psychosis and behavioral disturbances. To minimize side effects, these medications should be started at low dosages that are increased incrementally. |
American Family Physician February 1, 2005 Richard D. Blondell |
Ambulatory Detoxification of Patients with Alcohol Dependence An appropriate candidate for outpatient detoxification should have arrangements to start an alcohol treatment program and a responsible support person who can monitor progress, and should not have significant, acute, comorbid conditions or risk factors for severe withdrawal. |
American Family Physician January 15, 2005 Liya Davydov |
STEPS - New Drug Reviews Omalizumab is an immunomodulatory therapy for the control of symptoms in patients with moderate to severe allergic asthma uncontrolled with conventional therapy. |
American Family Physician August 15, 2004 Huggins & Looney |
Allergen Immunotherapy The major objectives of the practice are to reduce responses to allergic triggers that precipitate symptoms in the short term and to decrease inflammatory response and prevent development of persistent disease in the long term. |
American Family Physician January 15, 2003 Velez & Selwa |
Seizure Disorders in the Elderly Seizure disorders become increasingly common after the age of 60 years and can have a significant impact on functional status. The goal of antiepileptic drug therapy is to control seizures but preserve quality of life. |
American Family Physician December 1, 2005 Potter, Rindfleisch & Kraus |
Management of Active Tuberculosis Although the overall incidence of tuberculosis has been declining in the United States, it remains an important public health concern. Patients who present with symptoms of active tuberculosis (e.g., cough, weight loss, or malaise with known exposure to the disease) should be evaluated. |
American Family Physician September 15, 2005 Rindfleisch & Muller |
Diagnosis and Management of Rheumatoid Arthritis Rheumatoid arthritis is the most common inflammatory arthritis, affecting 0.8 percent of the adult population worldwide. It is a lifelong disease, although patients can go into remission. Physicians must be aware of common comorbidities. |
Nursing February 2010 Jeanne Held-Warmkessel |
How to prevent and manage Tumor lysis syndrome Potentially fatal, tumor lysis syndrome is a metabolic disturbance caused by the death of cancer cells during cancer treatment and the release of their intracellular components into the bloodstream. |
American Family Physician July 15, 2002 Bruce T. Vanderhoff & Rundsarah M. Tahboub |
Proton Pump Inhibitors: An Update Proton pump inhibitors (PPIs) are one of the most commonly prescribed classes of medications in the primary care setting and are considered a major advance in the treatment of acid-peptic diseases. |
American Family Physician January 1, 2007 Shashi & Subhash Bhatia |
Childhood and Adolescent Depression Safe and effective treatment of major depression in this age group requires accurate diagnosis, suicide risk assessment, and use of evidence-based therapies. |
American Family Physician July 15, 2004 Wu & Schiff |
Sarcoidosis This systemic granulomatous disease of unknown cause predominately affects young and middle-aged adults. Diagnosis is based on clinicoradiologic findings plus histologic evidence of noncaseating epithelioid granulomas, and exclusion of other granulomatous diseases. |
American Family Physician February 15, 2006 Rayner et al. |
Behavior Disorders of Dementia: Recognition and Treatment Psychosis may pose a greater challenge than cognitive decline for patients with dementia and their caregivers. Goals of treatment should include symptom reduction and preservation of quality of life. |
American Family Physician August 1, 2002 Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
Nurse Practitioner December 2009 Gujral & Collantes |
Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions. |
American Family Physician February 15, 2005 Beck, Sieber & Trejo |
Management of Cluster Headache Cluster headache, an excruciating, unilateral headache usually accompanied by conjunctival injection and lacrimation, can occur episodically or chronically, and can be difficult to treat. |
American Family Physician December 1, 2004 McConaghy & Smith |
Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. |
American Family Physician August 1, 2006 Warner et al. |
Antidepressant Discontinuation Syndrome Antidepressant discontinuation syndrome occurs in approximately 20% of patients after abrupt discontinuation of an antidepressant medication that was taken for at least six weeks. |
American Family Physician November 15, 2004 Peter A. Calabresi |
Diagnosis and Management of Multiple Sclerosis The diagnosis of multiple sclerosis should be made by a physician with experience in identifying the disease. Five disease-modifying treatments for multiple sclerosis have been approved by the U.S. Food and Drug Administration. |
Nursing August 2009 Pullen et al. |
Putting a face on systemic lupus erythematosus In this article, we'll tell you how to assess a patient for SLE and what to teach her about managing this chronic disorder. |
American Family Physician September 15, 2000 Kim S. Griswold, M.D., M.P.H. & Linda F. Pessar, M.D. |
Management of Bipolar Disorder A comprehensive management program, including collaboration between the patient's family physician and psychiatrist, should be implemented to optimize medical care... |
Nursing October 2009 Yvonne D'Arcy |
Overturning barriers to pain relief in older adults This article will describe how to lower the barriers to effective pain control in older patients and provide practical tips for helping them receive the full benefit from pharmacologic and nonpharmacologic therapies. |
American Family Physician September 15, 2005 Cobb & Crichlow |
STEPS: Duloxetine (Cymbalta) for Treatment of Major Depressive Disorder Duloxetine is safe and effective for the treatment of major depressive disorder. Because of its expense and the lack of data supporting its superiority over other antidepressants, it should be used as an alternative if other agents are ineffective or are not tolerated. |
American Family Physician August 15, 2005 Reid & Wheeler |
Hyperthyroidism: Diagnosis and Treatment Proper treatment of hyperthyroidism depends on recognition of the signs and symptoms of the disease and determination of the etiology. |
American Family Physician February 1, 2006 Lutfiyya et al. |
Diagnosis and Treatment of Community-Acquired Pneumonia When a patient presents with suspected community-acquired pneumonia, the physician should first assess the need for hospitalization using a mortality prediction tool, such as the Pneumonia Severity Index, combined with clinical judgment. |